Mar 28, 2017 - Allergan plc (AGN) in collaboration with Paratek Pharmaceuticals, Inc. (PRTK) has announced positive results from two phase III studies on sarecycline
Mar 27, 2017 - Thinly traded micro cap Foamix Pharmaceuticals (NASDAQ:FOMX) craters 47% premarket on light volume in response to its announcement of mixed results from two Phase 3 clinical trials assessing
Mar 27, 2017 - Two Phase 3 clinical trials assessing Allergan's (NYSE:AGN) orally administered sarecycline in people with moderate-to-severe acne met their 12-week primary efficacy endpoints. Based on the successful
Mar 24, 2017 - Thinly traded micro cap Xenon Pharmaceuticals (NASDAQ:XENE) is poised for a down day after announcing that lead dermatology candidate XEN801 failed to beat placebo in a Phase 2 clinical trial in peopl
Mar 24, 2017 - Companies in the News are:
Mar 23, 2017 - Accenture plc (NYSE:ACN) Q2 2017 Results Earnings Conference Call March 23, 2017, 08:00 AM ET Executives Angie Park - Managing Director and Head of Investor Relations Pierre Nanterme - Chairman and CE
Mar 23, 2017 - Accenture plc (ACN) reported mixed second-quarter fiscal 2017 results.
Mar 23, 2017 - Accenture Plc (ACN) reported mixed second-quarter fiscal 2017 results wherein bottom-line came ahead of the Zacks Consensus Estimate while top-line misses the same.
Mar 20, 2017 - These companies have the best earnings surprise track records on Wall Street this week.
Mar 20, 2017 - Accenture Plc (ACN) is set to report second-quarter fiscal 2017 results on Mar 23.